Skip to main content
. Author manuscript; available in PMC: 2013 Jul 18.
Published in final edited form as: Head Neck. 2012 Jan 20;34(11):1640–1647. doi: 10.1002/hed.21981

TABLE 1.

Selected patient, tumor, and treatment characteristics.

Characteristic No. of patients %
Sex
 Male 46 92
 Female 4 8
Primary tumor site
 Tonsil 19 38
 Base of tongue 25 50
 Unknown 3 6
 Hypopharynx 1 2
 Larynx 1 2
 Nasopharynx 1 2
T classification
 T0 3 6
 T1 15 30
 T2 26 52
 T3 4 8
 T4 2 4
N classification
 N1 4 8
 N2a 2 4
 N2b 34 68
 N2c 8 16
 N3 2 4
HPV
 Positive 46 92
 Negative (p16+) 4 8
FNA
 No 21 42
 Yes 29 58
Chemotherapy
 CDDP 43 86
 None 2 4
 Other* 5 10

Abbreviations: HPV, human papillomavirus; FNA, fine-needle aspiration; CDDP, cis-diamminedichloroplatinum.

*

3, 1, 1 patients received concomitant carboplatin, erbitux or carboplatin + taxol, respectively.